ISSN 1016-5169 | E-ISSN 1308-4488
Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2014; 42(2): 1-9

Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening

Ümit Yaşar Sinan1, Vedat Sansoy2
1Viranşehir State Hospital, Cardiology Clinic, Sanlıurfa, Turkey
2Istanbul University, Institute of Cardiology, Department of Cardiology, Istanbul, Turkey

Familial hypercholesterolaemia (FH) is an autosomal dominant genetic disorder characterized by elevated plasma levels of low-density lipoprotein-cholesterol (LDL-C) and increased risk of premature coronary heart disease. There are two types of FH, namely homozygous and heterozygous FH. FH is most commonly (85%) attributable to mutations in the LDL receptor (LDL-R) gene. Other rare causes are the mutations of genes encoding apolipoprotein B (Apo B), pro-protein convertase subtilisin/ kexin type 9 (PCSK9) and LDL adaptor protein 1 (LDLRAP 1). FH is both underdiagnosed and undertreated, particularly among children. Approximately 20% of patients are diagnosed and, of those, only a small minority receive appropriate treatment. The risk of premature coronary heart disease (CHD) is elevated about 20-fold in untreated FH patients. Early diagnosis of FH enables prompt treatment and prevention of consequent morbidity and mortality from premature CHD. There is no single internationally accepted set of criteria for the clinical diagnosis of FH. The most commonly used are the US (Make Early Diagnosis to Prevent Early Death) MEDPED, the UK (Simon Broome), and the Dutch Lipid Clinic sets of criteria that have been statistically and genetically validated. For early diagnosis and prevention of CVD, testing lipid levels in all first-degree relatives of diagnosed FH patients is necessary. Genetic screening for FH is generally not needed for diagnosis or clinical management, but may be useful when the diagnosis is uncertain.

How to cite this article
Ümit Yaşar Sinan, Vedat Sansoy. Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening. Turk Kardiyol Dern Ars. 2014; 42(2): 1-9

Corresponding Author: Vedat Sansoy, Türkiye
Manuscript Language: Turkish

Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
SCImago Journal Rank: 0.348

Quick Search

Copyright © 2023 Archives of the Turkish Society of Cardiology

Kare Publishing is a subsidiary of Kare Media.